Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School, Tokyo 113-8603, Japan.
Digestion. 2010;82(3):167-72. doi: 10.1159/000308361. Epub 2010 Jun 25.
Capsule endoscopy and balloon endoscopy, advanced modalities that now allow for full investigation of the entire small intestine, have revealed that non-steroidal anti-inflammatory drugs (NSAIDs) can cause a variety of abnormalities in the small intestine. Traditional NSAIDs can induce small intestinal injuries in over 50% of patients. Several studies have shown that the preventive effect of proton pump inhibitors does not extend to the small intestine, suggesting that concomitant therapy may be required to prevent small intestinal side effects associated with traditional NSAIDs use. Recently, several randomized controlled trials used capsule endoscopy to evaluate the preventive effect of certain drugs on NSAID-induced small intestinal injuries. These studies show that misoprostol and rebamipide have a preventive effect for NSAID-induced small intestinal mucosal injuries. However, these studies included only a small series of healthy volunteers and tested short-term NSAID treatment. Therefore, further extensive studies are clearly required to ascertain the beneficial effect of these drugs.
胶囊内镜和气囊内镜等先进技术现在可以对整个小肠进行全面检查,它们显示非甾体抗炎药(NSAIDs)可导致小肠出现多种异常。传统 NSAIDs 可使超过 50%的患者发生小肠损伤。多项研究表明质子泵抑制剂的预防作用并不能扩展到小肠,这表明可能需要联合治疗来预防与传统 NSAIDs 使用相关的小肠副作用。最近,几项随机对照试验使用胶囊内镜评估某些药物对 NSAID 诱导的小肠损伤的预防作用。这些研究表明米索前列醇和瑞巴派特对 NSAID 诱导的小肠黏膜损伤具有预防作用。然而,这些研究仅包括一小部分健康志愿者和短期 NSAID 治疗的测试。因此,显然需要进一步进行广泛的研究以确定这些药物的有益作用。